Editas Medicine Future Growth

How is Editas Medicine forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

-3.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:EDIT - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	28	-254	-275	-157	7
12/31/2024	24	-224	-230	-159	11
12/31/2023	16	-224	-214	-187	18
9/30/2022	26	-201	-176	-170	N/A
6/30/2022	32	-184	-171	-162	N/A
3/31/2022	26	-186	-174	-164	N/A
12/31/2021	26	-193	-172	-164	N/A
9/30/2021	24	-214	-176	-169	N/A
6/30/2021	81	-167	-189	-183	N/A
3/31/2021	92	-135	-180	-175	N/A
12/31/2020	91	-116	-187	-180	N/A
9/30/2020	92	-91	-106	-99	N/A
6/30/2020	33	-132	-79	-71	N/A
3/31/2020	24	-142	-73	-66	N/A
12/31/2019	21	-134	-47	-41	N/A
9/30/2019	14	-121	-86	-80	N/A
6/30/2019	25	-103	-66	-61	N/A
3/31/2019	30	-108	-57	-52	N/A
12/31/2018	32	-110	-50	-46	N/A
9/30/2018	29	-121	-76	-72	N/A
6/30/2018	21	-132	-96	-92	N/A
3/31/2018	17	-120	-104	-102	N/A
12/31/2017	14	-120	-11	-9	N/A
9/30/2017	11	-124	0	2	N/A
6/30/2017	6	-118	11	13	N/A
3/31/2017	6	-111	26	29	N/A
12/31/2016	6	-97	-54	-50	N/A
9/30/2016	6	-71	-48	-45	N/A
6/30/2016	6	-57	N/A	-39	N/A
3/31/2016	2	-86	N/A	-9	N/A

Earnings vs Savings Rate: EDIT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: EDIT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: EDIT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: EDIT's revenue (36.3% per year) is forecast to grow faster than the US market (7.1% per year).

High Growth Revenue: EDIT's revenue (36.3% per year) is forecast to grow faster than 20% per year.